New Drugs on the Horizon for Stroke and Hydrocephalus
Kristopher Kahle, MD, assistant professor of neurosurgery and of cellular and molecular physiology at Yale School of Medicine, recently published a study describing a new compound that could reduce swelling in the brain caused by stroke or hydrocephalus.
Dr. Jennifer Moliterno and the Yale Department of Neurosurgery Section of Neurosurgical Oncology for Primary Brain Tumors, is excited to announce the “The Susan Beris, M.D. Fund for Yale Brain Tumor Surgery Program.”
Dr. Jennifer Moliterno and the Yale Department of Neurosurgery Section of Neurosurgical Oncology for Primary Brain Tumors, is excited to announce the “The Susan Beris, M.D. Fund for Yale Brain Tumor Surgery Program.” Dr. Beris, a Yale-trained pediatrician, who had been in practice in western Connecticut for nearly 30-years, was diagnosed with a glioblastoma in 2018. She underwent a successful awake craniotomy for its removal and remains on adjuvant care overseen by Dr. Nick Blondin. In honor of the exceptional specialized care she received, Dr. Beris generously donated $100,000 to support this program. “Susie is an incredibly special person and I have admired her strength since the moment I met her and we are indebted to her generosity,” said Dr. Moliterno.
3rd Annual Lovemark ProAm at the Hudson Valley Country Club
The Lovemark Foundation hosted their 3rd Annual Lovemark ProAm at the Hudson Valley Country Club, raising money for brain tumor patient support. Dr. Moliterno, shown here with PGA golfer Jamie Lovemark, his wife Tiva and her son, Aydin Günel, serves as the Chief of Neurosurgical Oncology for Primary Brain Tumors and Co-Director of the Yale Brain Tumor Center at Smilow Cancer Hospital.
Sports Rush: Putting For Patients
A shoulder injury has kept Jamie Lovemark off the PGA Tour since January. He has worked his way back to the point where he can play a casual round, and he did so on Monday. Though he wasn’t exactly playing a major championship, the tournament still meant a lot to Lovemark. It benefitted the Lovemark Foundation he and his wife, Tiva, started to help patients suffering from brain tumors.Source: Fort Worth Weekly
Lowering blood pressure reduces brain bleeding in strokes
The search for treatments for spontaneous intracerebral hemorrhage, the most devastating type of stroke, which carries a 40% mortality rate, has been rife with disappointments. But a new study suggests that intensive blood pressure lowering may reduce the amount of bleeding in deep areas of the brain in patients with the condition, a team of Yale researchers report May 13 in the journal JAMA Neurology.
Yale Stroke Team the 1st worldwide to treat acute-stroke with a next-generation stent retriever and delivery microcatheter.
Drs. Michele Johnson and Charles Matouk (Section Chief of Neurovascular Surgery) were the first in the world to use a next-generation stent retriever and delivery microcatheter to physically remove a clot from the brain of two patients with acute ischemic stroke. The clots were removed within minutes affording these patients the best chance of great outcomes.
CTBTA Path of Hope Event Honors Yale Neurosurgeon Joe Piepmeier, MD With a Lifetime Achievement Award for his Dedication to Treating Patients with Brain Tumors
The Connecticut Brain Tumor Alliance (CTBTA) held their 5K Run/Walk in honor and support of brain tumor patients at Jennings Beach in Fairfield on Saturday, September 29, 2018. The event drew a record turn out and was sponsored by Smilow Cancer Hospital and Yale Cancer Center. Monies from the event go to patient support and research for brain tumors. Dr. Maxwell Laurans, a Yale neurosurgeon specialized in spine surgery, and Matthew Long, son of Anne Long, nurse coordinator for Yale Neurosurgical Oncology, both received awards for the fastest times in their respective age brackets for the 5K run.